Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedA new revision entry (Revision: v3.5.5) is added to the study history, and the previous entry (Revision: v3.5.4) is removed from the list, updating the record to reflect the latest version.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new version entry, Revision: v3.5.4, was added to the Record History, replacing the previous Revision: v3.5.3 and signaling an update to the study record.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now displays an updated UI/release revision label (Revision: v3.5.3 instead of v3.5.2), reflecting a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2 and Deleted Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.